Evidence map›Paper›PMID 33887324›Full record

ArticleThe Journal of biological chemistry

Active site architecture reveals coordination sphere flexibility and specificity determinants in a group of closely related molybdoenzymes.

Michel A Struwe, Palraj Kalimuthu, Zhenyao Luo, Qifeng Zhong, Daniel Ellis, Jing Yang, K C Khadanand, Jeffrey R Harmer, Martin L Kirk, Alastair G McEwan and 4 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Active Site Characterization of aInorganic chemistry · 2024
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Michel A StruweAustralian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld, Australia; Pharmazeutisches Institut, Christian-Albrechts-Universität Kiel, Kiel, Germany.
Palraj KalimuthuSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld, Australia.
Zhenyao LuoAustralian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld, Australia; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Qld, Australia.
Qifeng ZhongAustralian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld, Australia.
Daniel EllisAustralian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld, Australia.
Jing YangDepartment of Chemistry and Chemical Biology, The University of New Mexico, Albuquerque, New Mexico, USA.
K C KhadanandDepartment of Chemistry and Chemical Biology, The University of New Mexico, Albuquerque, New Mexico, USA.
Jeffrey R HarmerCentre for Advanced Imaging, The University of Queensland, Brisbane, Qld, Australia.
Martin L KirkInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Qld, Australia.
Alastair G McEwanAustralian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld, Australia.
Bernd ClementPharmazeutisches Institut, Christian-Albrechts-Universität Kiel, Kiel, Germany.
Paul V BernhardtSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld, Australia.
Bostjan KobeAustralian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld, Australia; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Qld, Australia.
Ulrike KapplerAustralian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Qld, Australia. Electronic address: u.kappler@uq.edu.au.
The University of Queensland · AUUniversity of New Mexico · USChristian-Albrechts-Universität zu Kiel · DE

Funding

Spectroscopic Studies of Molybdoenzymes & ModelsR01GM057378 · NIGMS · UNIVERSITY OF NEW MEXICO · PI MARTIN L KIRK · 1998 to 2026
$6.9M
NIGMS NIH HHS R01 GM057378
6 · The paper itself

Abstract

MtsZ is a molybdenum-containing methionine sulfoxide reductase that supports virulence in the human respiratory pathogen Haemophilus influenzae (Hi). HiMtsZ belongs to a group of structurally and spectroscopically uncharacterized S-/N-oxide reductases, all of which are found in bacterial pathogens. Here, we have solved the crystal structure of HiMtsZ, which reveals that the HiMtsZ substrate-binding site encompasses a previously unrecognized part that accommodates the methionine sulfoxide side chain via interaction with His182 and Arg166. Charge and amino acid composition of this side chain-binding region vary and, as indicated by electrochemical, kinetic, and docking studies, could explain the diverse substrate specificity seen in closely related enzymes of this type. The HiMtsZ Mo active site has an underlying structural flexibility, where dissociation of the central Ser187 ligand affected catalysis at low pH. Unexpectedly, the two main HiMtsZ electron paramagnetic resonance (EPR) species resembled not only a related dimethyl sulfoxide reductase but also a structurally unrelated nitrate reductase that possesses an Asp-Mo ligand. This suggests that contrary to current views, the geometry of the Mo center and its primary ligands, rather than the specific amino acid environment, is the main determinant of the EPR properties of mononuclear Mo enzymes. The flexibility in the electronic structure of the Mo centers is also apparent in two of three HiMtsZ EPR-active Mo(V) species being catalytically incompetent off-pathway forms that could not be fully oxidized.

Indexed as

Amino Acid SequenceBacterial ProteinsCatalysisCatalytic DomainHaemophilus influenzaeKineticsLigandsMetalloproteinsMolybdenumOxidation-ReductionOxidoreductasesProtein ConformationSequence Homology, Amino AcidSubstrate SpecificityBacterial ProteinsLigandsMetalloproteinsMolybdenumOxidoreductaseselectrochemistryelectron paramagnetic resonance (EPR)enzyme kineticsenzyme specificityenzyme structureHaemophilus influenzaemethionine sulfoxidemolybdenum

Identifiers

PMID33887324
PMCPMC8166771
OpenAlexW3154468880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.